To identify rapid and cost-effective drugs that target TBX2, the other report described a combined high-throughput target-based approach with a drug repurposing screen with the aim of identifying commercially available drugs that specifically target TBX2 and/or its homolog, TBX3 for the treatment of cancer [59]. This evidence concerns the gene TBX3 and cancer.